TGIF2 and astrocytoma (excluding glioblastoma): Kaplan-Meyer analysis revealed that higher TGIF2 expression associated with worse OS in subgroups including age >60, age ≤60, male, female, Race (White), WHO grade (G3), 1p/19q codeletion status (non-codel), histological type (astrocytoma), and primary therapy outcome (PD) (Figures 4A–I).